“Paradoxical wakefulness” induced by psychedelic 5-methoxy-N,N-dimethyltryptamine in mice
This pre-print mice study finds that 5-MeO-DMT delayed the onset of REM sleep as measured with EEG, and showed behavioural signals (e.g. head twitches) consistent with psychedelic effects, whilst during the waking stage the EEG measures were also showing signs of REM sleep (paradoxical wakefulness).
Authors
- Breant, B.
- Mengual, J. P.
- Bannerman, D.
Published
Abstract
Vigilance states - waking, slow-wave sleep (SWS) and paradoxical sleep, are thought to be controlled by several cortical and subcortical neuromodulatory circuits, among which the serotonergic (5-HT) system plays an important role. Recently, serotonergic psychedelics have attracted attention as potent antidepressants. While they are known to induce profound changes in subjective experience, the immediate and delayed effects of psychedelics on classical signatures of sleep-wake states remain under-investigated. To address this, we performed chronic electrophysiological recordings in the cortex of freely moving adult male mice following an injection of a short-acting psychedelic 5-methoxy-N,N-dimethyltryptamine (5- MeO-DMT). The most noticeable effect of 5-MeO-DMT administration was the suppression of paradoxical sleep and an acute induction of a mixed state of vigilance, characterised instead by prominent SWS-like slow waves on the EEG and LFP in awake, moving animals. We posit that the occurrence of this state in mice, which we refer to as “paradoxical wakefulness”, may be a rodent equivalent of the altered state of consciousness induced by psychedelics in humans.
Research Summary of '“Paradoxical wakefulness” induced by psychedelic 5-methoxy-N,N-dimethyltryptamine in mice'
Introduction
Mammalian vigilance is conventionally divided into wakefulness, slow-wave sleep (SWS, or NREM) and paradoxical sleep (PS, or REM), each defined by characteristic behavioural and electrophysiological markers. Serotonin (5-HT) is a major neuromodulator implicated in sleep–wake regulation and in mood disorders; selective serotonin reuptake inhibitors are known to suppress PS. Psychedelic compounds acting on 5-HT receptors have renewed therapeutic interest, but their immediate and delayed effects on canonical sleep–wake signatures are not well characterised. Bréant and colleagues set out to examine how the fast-acting psychedelic 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) affects vigilance states and cortical activity in freely moving mice. Using chronic electrophysiological recordings combined with behavioural assays, the study aimed to document acute changes in EEG, local field potentials (LFP) and multi-unit activity (MUA), to quantify effects on sleep architecture, and to test whether psychedelics can induce an altered, hybrid vigilance state during overt wakefulness.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- APA Citation
Bréant, B. J. B., Mengual, J. P., Hoerder-Suabedissen, A., Patel, J., Bannerman, D. M., Sharp, T., & Vyazovskiy, V. V. (2022). “Paradoxical wakefulness” induced by psychedelic 5-methoxy-N,N-dimethyltryptamine in mice. https://doi.org/10.1101/2022.12.11.519886
References (13)
Papers cited by this study that are also in Blossom
Barsuglia, J. P., Davis, A. K., Palmer, R. et al. · Frontiers in Psychology (2018)
Timmermann, C., Roseman, L., Schartner, M. et al. · Scientific Reports (2019)
Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)
Rucker, J., Iliff, J., Nutt, D. J. · Neuropharmacology (2017)
Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)
Barrett, F. S., Doss, M. K., Sepeda, N. D. et al. · Scientific Reports (2020)
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)
Halberstadt, A. L., Chatha, M., Klein, A. K. et al. · Neuropharmacology (2020)
Ermakova, A. O., Dunbar, F., Rucker, J. et al. · Journal of Psychopharmacology (2021)
Show all 13 referencesShow fewer
Dudysová, D., Janků, K., Šmotek, M. et al. · Frontiers in Pharmacology (2020)
González, J., Cavelli, M., Castro-Zaballa, S. et al. · ACS Pharmacology and Translational Science (2021)
Domenico, C., Haggerty, D., Mou, X. et al. · Cell Reports (2021)
Cited By (1)
Papers in Blossom that reference this study
Blackburne, G., Mcalpine, R. G., Fabus, M. et al. · Cell Reports (2025)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.